ARGINASE INHIBITION IMPROVES LEFT VENTRICULAR DYSFUNCTION IN MURINE DOXORUBICIN-INDUCED HEART FAILURE, AND INCREASED ARGINASE ACTIVITY CORRELATES WITH CARDIAC DYSFUNCTION IN PATIENTS WITH SYSTOLIC HEART FAILURE

被引：0
|
作者：
Hakuno, Daihiko [1 ]
Toya, Takumi [1 ]
Hamba, Yasuhito [1 ]
Shiraishi, Yasunaga [1 ]
Kujiraoka, Takehiko [1 ]
Adachi, Takeshi [1 ]
机构：
[1] Natl Def Med Coll, Tokorozawa, Saitama 3590042, Japan
来源：
JOURNAL OF VASCULAR RESEARCH | 2013年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [31] Predicting left ventricular systolic dysfunction in patients with symptoms and signs of heart failure in the community
    Jeyaseelan, S
    Fahey, T
    Goudie, B
    Pringle, S
    Donnon, P
    Sullivan, F
    Struthers, A
    HEART, 2006, 92 : A41 - A41
  • [32] Angiotensin converting enzyme inhibition in asymptomatic left ventricular systolic dysfunction and early heart failure
    Konstam, MA
    EUROPEAN HEART JOURNAL, 1995, 16 : 59 - 64
  • [33] CARDIAC FILLING PRESSURE BUT NOT LEFT VENTRICULAR SYSTOLIC DYSFUNCTION PREDICTS RENAL INSUFFICIENCY IN PATIENTS WITH CHRONIC HEART FAILURE
    Fernando, C. S.
    Sharar, H.
    Cheng, M.
    Moe, G. W.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S280 - S280
  • [34] Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction
    Löwbeer, C
    Gustafsson, SA
    Seeberger, A
    Bouvier, F
    Hulting, J
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2004, 64 (07): : 667 - 676
  • [35] From left ventricular dysfunction to heart failure
    Cleland, JGF
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1996, 89 (11): : 1397 - 1402
  • [36] PARADOXICAL INTRAVENTRICULAR SYSTOLIC FLOW PREDICTS HOSPITALIZATION FOR HEART FAILURE IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
    Swiatkiewicz, Iwona
    Igata, Sachiyo
    Nishimura, Marin
    Strachan, Monet
    Raisinghani, Ajit
    DeMaria, Anthony
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1534 - 1534
  • [37] Effects of oral tolvaptan on left ventricular dilatation and function in patients with heart failure and left ventricular systolic dysfunction
    Orlandi, C
    Udelson, J
    Zimmer, C
    Ouyang, J
    Yamamura, Y
    Ozaki, A
    Konstam, M
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S263 - S263
  • [38] Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction
    Udelson, JE
    Konstam, MA
    JOURNAL OF CARDIAC FAILURE, 2002, 8 (06) : S465 - S471
  • [39] Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice
    Toya, Takumi
    Hakuno, Daihiko
    Shiraishi, Yasunaga
    Kujiraoka, Takehiko
    Adachi, Takeshi
    PHYSIOLOGICAL REPORTS, 2014, 2 (09):
  • [40] Value of ECGs in identifying heart failure due to left ventricular systolic dysfunction
    Davie, AP
    Love, MP
    McMurray, JJV
    BRITISH MEDICAL JOURNAL, 1996, 313 (7052): : 300 - 301
12345